ZA973885B - Cationic virosomes as transfer system for genetic material - Google Patents
Cationic virosomes as transfer system for genetic materialInfo
- Publication number
- ZA973885B ZA973885B ZA973885A ZA973885A ZA973885B ZA 973885 B ZA973885 B ZA 973885B ZA 973885 A ZA973885 A ZA 973885A ZA 973885 A ZA973885 A ZA 973885A ZA 973885 B ZA973885 B ZA 973885B
- Authority
- ZA
- South Africa
- Prior art keywords
- transfer system
- genetic material
- cationic virosomes
- virosomes
- cationic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96107282 | 1996-05-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA973885B true ZA973885B (en) | 1998-11-06 |
Family
ID=8222763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA973885A ZA973885B (en) | 1996-05-08 | 1997-05-06 | Cationic virosomes as transfer system for genetic material |
Country Status (28)
Country | Link |
---|---|
US (1) | US6210708B1 (xx) |
EP (1) | EP0902682A2 (xx) |
JP (1) | JP2000509404A (xx) |
KR (1) | KR100536983B1 (xx) |
CN (1) | CN1271992C (xx) |
AR (1) | AR007054A1 (xx) |
AU (1) | AU710170B2 (xx) |
BG (1) | BG102880A (xx) |
BR (1) | BR9709224A (xx) |
CA (1) | CA2253561A1 (xx) |
CO (1) | CO4600638A1 (xx) |
CZ (1) | CZ299809B6 (xx) |
EA (1) | EA003130B1 (xx) |
GT (1) | GT199700058A (xx) |
HR (1) | HRP970234B1 (xx) |
HU (1) | HUP9901790A3 (xx) |
ID (1) | ID17934A (xx) |
NO (1) | NO327726B1 (xx) |
NZ (1) | NZ332666A (xx) |
OA (1) | OA10916A (xx) |
PA (1) | PA8429201A1 (xx) |
PE (1) | PE65198A1 (xx) |
PL (1) | PL199201B1 (xx) |
SK (1) | SK152698A3 (xx) |
SV (1) | SV1997000032A (xx) |
TN (1) | TNSN97080A1 (xx) |
WO (1) | WO1997041834A1 (xx) |
ZA (1) | ZA973885B (xx) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030113347A1 (en) * | 1991-05-08 | 2003-06-19 | Schweiz. Serum- & Impfinstitut Bern | Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them |
AU9224398A (en) * | 1997-09-08 | 1999-03-29 | Promega Corporation | Method of (in vivo) transformation utilizing lipid vehicles |
SE513149C2 (sv) * | 1997-12-05 | 2000-07-17 | Katarina Edwards | Läkemedelsdistributionssystem med tvåstegsmålsökning, till specifika celler eller vävnad och till dess cellkärna |
CZ20021216A3 (cs) * | 1999-10-08 | 2002-10-16 | Nika Health Products Limited | Lipidové váčky obsahující DOSPER |
US6722282B2 (en) * | 1999-12-17 | 2004-04-20 | Schott Glas | Ignition capsule, which can be inductively activated, for occupant restraint systems, and a test circuit for said ignition capsule |
EP1252897A4 (en) * | 2000-01-21 | 2003-07-30 | Hisamitsu Pharmaceutical Co | MEDICINES FOR GENE THERAPY |
JP2004536607A (ja) * | 2001-07-23 | 2004-12-09 | オニックス ファーマシューティカルズ,インコーポレイティド | 標的化されたヒト癌細胞において選択的に複製するウイルス変異体 |
KR100411234B1 (ko) * | 2001-08-14 | 2003-12-18 | 한국과학기술원 | 올리고뉴클레오티드 혼성화 미셀 및 그의 제조방법 |
WO2003038103A1 (en) * | 2001-10-29 | 2003-05-08 | Atso Raasmaja | Method for gene transfection using synergistic combinations of cationic lipids and cationic polymers |
US20040028687A1 (en) * | 2002-01-15 | 2004-02-12 | Waelti Ernst Rudolf | Methods and compositions for the targeted delivery of therapeutic substances to specific cells and tissues |
US20040176283A1 (en) * | 2002-04-01 | 2004-09-09 | Robinson John A. | Methods and compositions for the design of synthetic vaccines |
CN100488491C (zh) * | 2002-11-21 | 2009-05-20 | 派维翁生物技术有限公司 | 高效融合小泡,其制备方法和含有该小泡的药物组合物 |
US20090208478A1 (en) * | 2003-10-24 | 2009-08-20 | Gencia Corporation | Transducible polypeptides for modifying metabolism |
US8507277B2 (en) | 2003-10-24 | 2013-08-13 | Gencia Corporation | Nonviral vectors for delivering polynucleotides |
US20090123468A1 (en) | 2003-10-24 | 2009-05-14 | Gencia Corporation | Transducible polypeptides for modifying metabolism |
US8133733B2 (en) | 2003-10-24 | 2012-03-13 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to target tissues |
US8062891B2 (en) | 2003-10-24 | 2011-11-22 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to plants |
CA2543257C (en) | 2003-10-24 | 2013-12-31 | Gencia Corporation | Methods and compositions for delivering polynucleotides |
DE102004057303A1 (de) * | 2004-11-26 | 2006-06-01 | Merck Patent Gmbh | Stabile Kristallmodifikationen von DOTAP Chlorid |
US20070172520A1 (en) * | 2005-11-18 | 2007-07-26 | University Of South Florida | Immunotargeting of Nonionic Surfactant Vesicles |
ES2551892T3 (es) * | 2006-09-15 | 2015-11-24 | Ottawa Health Research Institute | Rhabdovirus oncolítico |
KR101242113B1 (ko) * | 2010-10-22 | 2013-03-19 | 고마바이오텍(주) | 유전자 전달용 양이온성 센다이 f/hn 바이로좀 복합체 |
WO2013032643A2 (en) * | 2011-08-31 | 2013-03-07 | Dicerna Pharmaceuticals, Inc. | Lipids capable of conformational change and their use in formulations to deliver therapeutic agents to cells |
US20140335117A1 (en) * | 2011-10-07 | 2014-11-13 | Skau Aps | Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses |
AU2017336199B2 (en) | 2016-09-27 | 2020-08-20 | Camurus Ab | Mixtures and formulations comprising an alkyl ammonium EDTA salt |
CN109055432B (zh) * | 2018-08-16 | 2020-10-13 | 南京科佰生物科技有限公司 | 慢病毒感染试剂及其制备方法与应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4261975A (en) | 1979-09-19 | 1981-04-14 | Merck & Co., Inc. | Viral liposome particle |
US5264618A (en) * | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
PL296382A1 (en) * | 1991-02-02 | 1993-11-02 | Nika Health Products Ltd Li Li | Artificial membrane beads containing functionally active peptides responsible for fusion as a drug administering system |
DE69229703T2 (de) * | 1991-05-08 | 2000-04-27 | Schweiz Serum & Impfinst | Wiederhergestellte Influenza-Virosomen mit immunostimulierenden und immunoverstärkenden Eigenschaften und diese enthaltende Impfstoffe |
AU3614493A (en) | 1992-02-04 | 1993-09-01 | Chiron Corporation | Non-toxic lipid vaccine formulations |
US5631237A (en) | 1992-12-22 | 1997-05-20 | Dzau; Victor J. | Method for producing in vivo delivery of therapeutic agents via liposomes |
US5578475A (en) * | 1993-07-12 | 1996-11-26 | Life Technologies, Inc. | Composition and methods for transfecting eukaryotic cells |
WO1995032706A1 (en) * | 1994-05-31 | 1995-12-07 | Inex Pharmaceuticals Corp. | Virosome-mediated intracellular delivery of therapeutic agents |
FR2726764B1 (fr) | 1994-11-14 | 1997-01-31 | Pasteur Merieux Serums Vacc | Adjuvant pour composition vaccinale |
-
1997
- 1997-05-04 SK SK1526-98A patent/SK152698A3/sk unknown
- 1997-05-04 CN CNB971962324A patent/CN1271992C/zh not_active Expired - Fee Related
- 1997-05-04 AU AU27766/97A patent/AU710170B2/en not_active Ceased
- 1997-05-04 HU HU9901790A patent/HUP9901790A3/hu unknown
- 1997-05-04 EP EP97921852A patent/EP0902682A2/en not_active Withdrawn
- 1997-05-04 EA EA199800992A patent/EA003130B1/ru not_active IP Right Cessation
- 1997-05-04 KR KR1019980708906A patent/KR100536983B1/ko not_active IP Right Cessation
- 1997-05-04 WO PCT/EP1997/002268 patent/WO1997041834A1/en active IP Right Grant
- 1997-05-04 BR BR9709224A patent/BR9709224A/pt unknown
- 1997-05-04 PL PL329853A patent/PL199201B1/pl not_active IP Right Cessation
- 1997-05-04 NZ NZ332666A patent/NZ332666A/xx unknown
- 1997-05-04 CZ CZ0361498A patent/CZ299809B6/cs not_active IP Right Cessation
- 1997-05-04 JP JP9539526A patent/JP2000509404A/ja active Pending
- 1997-05-04 CA CA002253561A patent/CA2253561A1/en not_active Abandoned
- 1997-05-06 ZA ZA973885A patent/ZA973885B/xx unknown
- 1997-05-07 GT GT199700058A patent/GT199700058A/es unknown
- 1997-05-07 TN TNTNSN97080A patent/TNSN97080A1/fr unknown
- 1997-05-07 HR HR970234A patent/HRP970234B1/xx not_active IP Right Cessation
- 1997-05-07 CO CO97024481A patent/CO4600638A1/es unknown
- 1997-05-07 PE PE1997000354A patent/PE65198A1/es not_active Application Discontinuation
- 1997-05-07 SV SV1997000032A patent/SV1997000032A/es unknown
- 1997-05-08 PA PA19978429201A patent/PA8429201A1/es unknown
- 1997-05-08 AR ARP970101917A patent/AR007054A1/es not_active Application Discontinuation
- 1997-05-09 ID IDP971533A patent/ID17934A/id unknown
-
1998
- 1998-10-29 BG BG102880A patent/BG102880A/xx unknown
- 1998-11-04 NO NO19985137A patent/NO327726B1/no not_active IP Right Cessation
- 1998-11-06 OA OA9800214A patent/OA10916A/en unknown
-
1999
- 1999-10-08 US US09/414,872 patent/US6210708B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9901790A3 (en) | Cationic virosomes as transfer system for genetic material | |
GB2322438B (en) | Feed system | |
AU1830200A (en) | Cationic liposomes for gene transfer | |
IL127416A0 (en) | Method for enhancing gene transfer | |
CZ20001713A3 (cs) | Způsob výroby citalopramu | |
EP0997530A4 (en) | DNA POLYMERASE RELATED FACTORS | |
GB9719727D0 (en) | New plant genes | |
IL134059A0 (en) | Process for preparing aminoarylacetylenes | |
EG23935A (en) | Process for preparing eprosartin | |
EG22077A (en) | Process for preparing 4-substituted-ih-indole-3 glyoxamides | |
IL126184A (en) | Process for preparing pentafluoropentanol | |
GB9703957D0 (en) | Tempering system | |
AU2421301A (en) | Material transfer system | |
GB9723540D0 (en) | Support means | |
GB2330510B (en) | Plant support | |
IL133288A (en) | Process for preparing 3-isochromanone | |
GB9706469D0 (en) | Genetic method | |
IL125646A0 (en) | Process for preparing n-pyruvyl-l-proline | |
IL121130A0 (en) | Vertical adjusting support system | |
LT98059A (en) | Process for preparing cationic flockulant | |
GB9909259D0 (en) | Material transfer system | |
GB9700474D0 (en) | Support system for horses | |
GB9709668D0 (en) | Safety support for plants | |
GB9805373D0 (en) | Central heating system | |
TW369803U (en) | Modified water-wal temperature system for greenhouses |